Formulation of sustained-release verapamil HCl and diltiazem HCl semisolid matrix capsules

Pharmaceutical Development and Technology

Volumn 13, Issue 2, 2008, Pages 115-125

  Nguyen, Chien N ^a   Christensen, J Mark ^a   Ayres, James W ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Cetyl alcohol; Diltiazem HCl; Gelucire 50 13; Hot melt filling; Semisolid matrix; Stearic acid; Sustained release; Verapamil HCl

Indexed keywords

DILTIAZEM; GELATIN; GELUCIRE; HEXADECANOL; MATRIX PROTEIN; STEARIC ACID; VERAPAMIL;

ARTICLE; DIFFUSION; DRUG CAPSULE; DRUG SOLUBILITY; DRUG STORAGE; HYDROPHILICITY; LIPOPHILICITY; PRIORITY JOURNAL; STORAGE TEMPERATURE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION;

CAPSULES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DILTIAZEM; SOLUBILITY; VERAPAMIL;

EID: 41549164864     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450701831070     Document Type: Article

References (13)

1. Galal S, EL Massik MA, Abdallah OY, Daabis NA. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires. Drug Dev. Ind. Pharmacy 2004;30(8):817-829.
2. Wu P, Tsai M, Huang Y, Chang J, Tsai Y. In vitro and in vivo evaluation of potassium chloride sustained release formulation prepared with saturated polyglycolyed glycerides matrices. Int. J. Pharm. 2002;243(1-2):119-124.
3. Esquisabel A, San Vicente A, Igartua M, Hernandez RM, Gascon AR, Calvo MB, Pedraz JL. Influence of melting point and hydrophilic/lipophilic balance on the release of salbutamol sulfate from lipid matrixes. Pharma Sci. 1996;6(5):365-369.
4. Choy YW, Nurzalina K, Yuen KH. Significance of lipid matrix aging on in vitro release and in vivo bioavailability. Int. J. Pharm. 2005;299(1-2):55-64.
5. Khan N, Craig DQM. The influence of drug incorporation on the structure and release properties of solid dispersions in lipid matrices. J. Control. Release 2003;93(3):355-368.
6. Sutananta W, Craig DQM, Newton JM. An evaluation of the mechanisms of drug release from glyceride bases. J. Pharmacy Pharmacol. 1995;47(3):182-187.
7. Sutananta W, Craig DQM, Newton JM. An investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glyceride bases. J. Pharmacy Pharmacol. 1995;47(5);355-359.
8. Vippagunta SR, Maul KA, Tallavajhala S, Grant DJW. Solidstate characterization of nifedipine solid dispersions. Int. J. Pharm. 2002;236(1-2):111-123.
9. Ratsimbazafy V, Bourret E, Duclos R, Brossard C. Rheological behavior of drug suspensions in Gelucire mixtures and proxyphylline release from matrix hard gelatin capsules. Eur. J. Pharm. Biopharm. 1999;48(3):247-252.
10. Perissutti B, Rubessa F, Princivalle F. Solid dispersions of carbamazepine with Gelucire 44/14 and 50/13. Pharma Sci 2000;10(6):479-484.
11. Kopcha, M, Lordi NG. Effect of physical and chemical properties on drug release from selected thermosoftening vehicles. J. Pharmacy Pharmacol. 1992;44(2):79-83.
12. Wade A, Weller PJ. Handbook of Pharmaceutical Excipients; 2nd Ed. Oxford and Northampton, UK: Arden press and the Royal Pharmaceutical Society of Great Britain; 1994;99-103:494-497.
13. Ainaoui A, Ouriemchi EM, Bidah D, El Amrani MK, Vergnaud JM. Process of drug release with oral dosage forms with a lipidic Gelucire matrix. J. Polym. Eng. 1997;17(3):245-255.